The efficacy and safety of photodynamic therapy for central serous chorioretinopathy
Not Applicable
- Conditions
- Central serous chorioretinopathy
- Registration Number
- JPRN-UMIN000022126
- Lead Sponsor
- Kyoto Prefectual Univercity of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. drug allery to verteporfin 2. pregnant or expecting pregnancy 3. porphyria 4. macular diseases other than central serous chorioretinopathy 5. others (inappropriate case judged by investigator or subinvestigators)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Resolution of serous retinal detachment of 1week, 1month, 3months, 6months, and 1year after photodynamic therapy
- Secondary Outcome Measures
Name Time Method